Louis Burt Nabors

Louis Burt Nabors

UNVERIFIED PROFILE

Are you Louis Burt Nabors?   Register this Author

Register author
Louis Burt Nabors

Louis Burt Nabors

Publications by authors named "Louis Burt Nabors"

Are you Louis Burt Nabors?   Register this Author

13Publications

971Reads

46Profile Views

Handedness and the risk of glioma.

J Neurooncol 2018 May 13;137(3):639-644. Epub 2018 Jan 13.

Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center & Research Institute, 12902 Magnolia Drive, Tampa, FL, 33612-9416, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-018-2759-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5924459PMC
May 2018

Central Nervous System: Notable Developments in the Management of Primary and Recurrent Gliomas.

J Natl Compr Canc Netw 2016 05;14(5 Suppl):681-4

Presented by Louis Burt Nabors, MD, Department of Neurology, Division of Neuro-Oncology, University of Alabama at Birmingham, Birmingham, Alabama.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2016.0192DOI Listing
May 2016

Central Nervous System Cancers, Version 1.2015.

J Natl Compr Canc Netw 2015 Oct;13(10):1191-202

From University of Alabama at Birmingham Comprehensive Cancer Center; City of Hope Comprehensive Cancer Center; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; Yale Cancer Center/Smilow Cancer Hospital; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; The University of Texas MD Anderson Cancer Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of Washington/Seattle Cancer Care Alliance; Roswell Park Cancer Institute; Duke Cancer Institute; UC San Diego Moores Cancer Center; University of Michigan Comprehensive Cancer Center; Memorial Sloan Kettering Cancer Center; St. Jude Children's Research Hospital/University of Tennessee Health Science Center; Massachusetts General Hospital Cancer Center; American Brain Tumor Association; Vanderbilt-Ingram Cancer Center; Mayo Clinic Cancer Center; Robert H. Lurie Comprehensive Cancer Center of Northwestern University; Stanford Cancer Institute; Fred & Pamela Buffet Cancer Center; Huntsman Cancer Institute at the University of Utah; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; Moffitt Cancer Center; Fox Chase Cancer Center; Dana-Farber/Brigham and Women's Cancer Center; National Comprehensive Cancer Network.

View Article

Download full-text PDF

Source
http://www.jnccn.org/content/13/10/1191.full.pdf
Web Search
http://dx.doi.org/10.6004/jnccn.2015.0148DOI Listing
October 2015

Growth factor dependent regulation of centrosome function and genomic instability by HuR.

Biomolecules 2015 Mar 20;5(1):263-81. Epub 2015 Mar 20.

Department of Neurology, University of Alabama at Birmingham, 510 20th Street South, FOT 1020, Birmingham, AL 35209, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/biom5010263DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4384122PMC
March 2015

Central nervous system cancers, version 2.2014. Featured updates to the NCCN Guidelines.

J Natl Compr Canc Netw 2014 Nov;12(11):1517-23

From University of Alabama at Birmingham Comprehensive Cancer Center; City of Hope Comprehensive Cancer Center; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; The University of Texas MD Anderson Cancer Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of Washington/Seattle Cancer Care Alliance; Memorial Sloan Kettering Cancer Center; Roswell Park Cancer Institute; Duke Cancer Institute; UC San Diego Moores Cancer Center; American Brain Tumor Association; University of Michigan Comprehensive Cancer Center; St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; Massachusetts General Hospital Cancer Center; Vanderbilt-Ingram Cancer Center; Robert H. Lurie Comprehensive Cancer Center of Northwestern University; Stanford Comprehensive Cancer Center; Fred & Pamela Buffett Cancer Center at The Nebraska Medical Center; Huntsman Cancer Institute at the University of Utah; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; Moffitt Cancer Center; Dana-Farber/Brigham and Women's Cancer Center; and National Comprehensive Cancer Network.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4337873PMC
http://dx.doi.org/10.6004/jnccn.2014.0151DOI Listing
November 2014

Cilengitide: an RGD pentapeptide ανβ3 and ανβ5 integrin inhibitor in development for glioblastoma and other malignancies.

Future Oncol 2011 Mar;7(3):339-54

Department of Surgery, Division of Neurosurgery, 047 Baker House, Duke University Medical Center, Box 3624, Durham, NC 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon.11.8DOI Listing
March 2011